Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.39 |
| ▸ | CDK9 | P50750 | 2/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17485921 | 0.94 | HDAC1 (0.40) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL3375825 | 0.92 | TSHR (0.50) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL12212062 | 0.88 | TSHR (0.43) | TSHRNPY5RCCNT1CDK9POLB | |
| SCHEMBL13981576 | 0.86 | NPY5R (0.42) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL2493713 | 0.86 | TSHR (0.44) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL16062693 | 0.86 | POLB (0.46) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL23822678 | 0.84 | TSHR (0.43) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL915242 | 0.84 | TSHR (0.43) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL1760137 | 0.82 | NPY5R (0.42) | TSHRNPY5RCCNT1CDK9TLR8 | |
| SCHEMBL13981237 | 0.82 | ENPP2 (0.51) | TSHRNPY5RCCNT1CDK9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713318-B2 | Short conjugated oligoelectrolytes and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713318-B2 | Short conjugated oligoelectrolytes and uses thereof | ACP1, TLR3, CD14 | TSHR 4075/4885NPY5R 4753/4885CCNT1 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.